| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 2 | 0.628 | 0.423 | 1.0E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
selectin E | 0.447 | 0.808 | 7.9E-10 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
zinc finger homeobox 3 | 0.621 | 0.654 | 0.45 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 2009 | 2018 | ||||||||
|
desmin | 0.460 | 0.846 | 8.8E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
NK2 homeobox 5 | 0.533 | 0.692 | 0.95 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2010 | 2018 | ||||||||
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2010 | 2018 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2010 | 2018 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
potassium voltage-gated channel subfamily A member 5 | 0.606 | 0.500 | 1.1E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
SRY-box transcription factor 5 | 0.545 | 0.769 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
caveolin 2 | 0.575 | 0.692 | 2.7E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
aminopeptidase O (putative) | 0.729 | 0.423 | 5.0E-15 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2012 | 2018 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4 | 0.617 | 0.269 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2018 | ||||||||
|
spectrin repeat containing nuclear envelope protein 2 | 0.623 | 0.692 | 1.7E-25 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2018 | ||||||||
|
Wnt family member 8A | 0.839 | 0.192 | 1.0E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
paired related homeobox 1 | 0.543 | 0.769 | 0.24 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
heart and neural crest derivatives expressed 2 | 0.612 | 0.500 | 0.40 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2017 | 2018 |